September 23rd, 2024 (Shanghai) — We are glad to announce that Dr. George Frodsham, the Founder & Chief Executive Officer of MediSieve, will be presenting at the ACCESS CHINA Partnering Forum – Autumn Virtual Showcase during September 24th to 25th, and 27th, 2024. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the Western biopharma industry.
About MediSieve
MediSieve is an innovative BioTech company based in the White City Innovation District of West London. A spin-off from University College London, MediSieve has developed a technology called Magnetic Blood Filtration, a transformative platform that provides the ability to physically remove or isolate specific substances directly from the bloodstream of patients. The company has a pipeline of both internal and partnered assets targeting largely underserved conditions and patient populations in areas including gene therapy, oncology, autoimmune diseases, and inflammation. Different assets provide value by either removing harmful agents that cause disease or prevent therapies or by isolating valuable agents for downstream use such as diagnostics.
About the speaker
Dr. George Frodsham is the CEO and founder of MediSieve, a London-based biotech that has developed a platform technology that enables the specific removal of harmful substances from the bloodstream. George spun out MediSieve from University College London following his PhD in biochemical engineering. He has received business and entrepreneurship training from the London Business School, the Royal Academy of Engineering, and the Royal Society of Edinburgh. In 2019, George was awarded the “Innovator of the Year” award by the Biotechnology and Biological Sciences Research Council and named one of MIT Tech Review’s “30 under 30”.
About ACCESS CHINA Partnering Forum
ACCESS CHINA Partnering Forum – Autumn Virtual Showcase is scheduled to be held on September 24th to 25th, and 27th, 2024, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, audience can have access to innovative pharma and healthcare products from worldwide.
Conference Name: ACCESS CHINA Partnering Forum
Date & Time: Sep 24 – 25 (live), and 27 (VoD) 2024, China time
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 500+ participants Online; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs
View more information at https://biotochina.org/
REGISTER
To Register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
BioToChina.org 